News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

News in the Parkinson's Disease Community

Cynapsus Therapeutics Parkinsonís Disease Candidate Gets FDA Fast Track Designation

New Test May Help Detect Parkinsonís Disease in Early Stages of Life

Simple Eye Test May Detect Parkinsonís Disease

Manufacturing Dopamine in the Brain with Gene Therapy

NeuroDerm Initiates Patient Enrollment in a Phase III Trial of ND0612L for the Treatment of PD

Researchers Examine How Parkinsonís Disease Alters Brain Activity Over Time

Leukemia Drug Proven Effective Against Parkinsonís Disease

Cynapsus Announces Publication of Data for the Treatment of OFF Episodes in Patients with PD

Parkinsonís: Mutant Enzyme, a-Synuclein Interaction May Be Preventable

National Parkinson Foundation (NPF) and the Parkinson's Disease Foundation (PDF) Complete Merger to Form the Parkinson's Foundation

Study Shows Cancer Drug Raises Dopamine Levels in Parkinsonís Patients

Parkinson's Disease Biomarker Found in Patient Urine Samples

Johns Hopkins Researchers Reveal Novel Protein and Involvement in Parkinsonís Disease

Scientists Offer New View on Origins of Parkinson's Disease

NeuroDerm Presents Three Posters at the 20th International Congress of Parkinsonís Disease and Movement Disorders

MS Drug Could Prove Effective Parkinson's Treatment

UCLA Scientists Discover Protective Strategy Against Pesticide-linked Parkinsonís Disease

New Gene Shown to Cause Parkinson's Disease

Great Lakes Neurotech Validation Studies on Wearable Tech for Parkinsonís to be Highlighted at International Conference

NeuroDerm Announces Patient Enrollment in Long-Term Safety Trial of ND0612 for PD

U.S. Approves First drug for Psychosis Linked to Parkinson's Disease

Adamas Pharma (ADMS) Announces ADS-5102 Phase 3 Met Primary, Key Secondary Endpoints as LID Treatment

back to top